All In MedTech

Device Trial Radar · NCT02674269

Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2")

A Randomized Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botulinum Toxin (Botox®) Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2")

Last checked: Nov 20, 2026Latest source record: Jun 16, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Oct 2016

Primary completion

Oct 2016

Study completion Oct 2016

Sponsor

Lead sponsor
UroGen Pharma Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Feb 4, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will investigate the safety and efficacy of UroGen's TC-3 Gel for sustained release of Botulinum Toxin A (BTX) in urinary bladder in patients with idiopathic overactive bladder.

Conditions

  • Overactive Bladder

Interventions

  • 300 IU of BotuGelTM (60ml)Drug

    One intravesical instillation of 300 IU of botox in 60 ml of TC-3 gel

  • 400 IU of BotuGelTM (60ml)Drug

    One intravesical instillation of 400 IU of botox in 60 ml of TC-3 gel

  • TC-3 GelDevice

    Intravesical instillation of 60 ml TC-3 gel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Urinary retentionTime frame: 6 weeks

3 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Rambam Health Care Campus

    Haifa, Israel

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.